Results build on previously reported reductions in virus load, illness severity, improved quality of life from a Phase 2a placebo-controlled challenge study evaluating oral vapendavir BARCELONA, Spain, Sept. 8, 2026 /PRNewswire/ -- Altesa BioSciences, a clinical-stage pharmaceutical...